October 14, 2009 (FinancialWire) — Resverlogix Corp. (TSX: RVX) (OTC: RVXCF) has named A. Brad Cann as its chief financial officer. He previously worked for Royal Host Real Estate Investment Trust, where he most recently served as EVP and CFO.

Prior to joining Royal Host, Cann worked as a financial and business consultant and held management positions with several companies including CFO of a sulphur export development firm.

Canada-based Resverlogix is a biotechnology company focused on delivering novel therapeutics for diseases with significant unmet medical needs. The company is developing an oral small molecule therapeutic to treat atherosclerosis and cardiovascular disease.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.